The agency said in a press release that the Sunrise-based company settled the allegations without admitting or denying them.
Regulators alleged that that on numerous occasions, Pediatrix used hindsight to select favorable exercise prices for employee and officer stock option grants without accurately reporting the financial impact of the grants to investors.
The complaint alleges that Pediatrix failed to recognize a total of $8.8 million in compensation expense which resulted in an overstatement of pre-tax earnings amounting to 6.7 percent over the three year period.
Pediatrix, which changed its name to MEDNAX at the end of last year, agreed to be enjoined from violating securities laws in the future.
To see more of the Sun Sentinel or to subscribe to the newspaper, go to http://www.sun-sentinel.com/. Copyright (c) 2009, Sun Sentinel, Fort Lauderdale, Fla. Distributed by McClatchy-Tribune Information Services. For reprints, email tmsreprints@permissionsgroup.com, call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index